Alam Kamran 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2023-05-31+6,230→ 291,042 total
Footnotes (2)
- [F1]Represents a performance restricted stock unit ("PRSU") award. The PRSUs were awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The PRSUs covered by this report vested upon certification.
- [F2]Each PRSU represented a contingent right to receive one share the Issuer's common stock.